Medpace Holdings (MEDP) Operating Expenses (2015 - 2026)

Medpace Holdings has reported Operating Expenses for 12 years, with the latest figure at $565.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 26.98% year-over-year to $565.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (up 24.41% YoY), and the FY2025 full-year result was $2.0 billion, up 20.04% from the prior year.
• Operating Expenses for Q1 2026 stood at $565.1 million, up from $555.2 million in the prior quarter.
• The five-year high for Operating Expenses was $565.1 million in Q1 2026, with the low at $266.7 million in Q1 2022.
• Historically, Operating Expenses has averaged $409.0 million across 5 years, with a median of $411.1 million in 2023.
• Annual changes were most pronounced in 2024 — Operating Expenses gained 0.03% — and 2025, when it jumped 35.01%.
• Medpace Holdings' Operating Expenses stood at $317.7 million in 2022, then grew by 29.41% to $411.1 million in 2023, then climbed by 0.03% to $411.2 million in 2024, then surged by 35.01% to $555.2 million in 2025, then increased by 1.79% to $565.1 million in 2026.
• The last three Operating Expenses figures came in at $565.1 million (Q1 2026), $555.2 million (Q4 2025), and $518.1 million (Q3 2025), per Business Quant data.